Abstract: A system and method are disclosed for using a camera image of a user's eye as a visual stimulus for the calibration point in an eyetracking calibration system. A camera image of a user's eye is generated on a user display using an eyetracker. The camera image of the user's eye is used as a visual stimulus of a calibration point. In an embodiment, the center of the pupil of the camera image of the user's eye represents the coordinates of the calibration point on the user display. In another embodiment, the center of the corneal reflection of the camera image of the user's eye represents the coordinates of the calibration point on the user display.

Abstract: A system and method are disclosed for using a camera image of a user's eye as a visual stimulus for the calibration point in an eyetracking calibration system. A camera image of a user's eye is generated on a user display using an eyetracker. The camera image of the user's eye is used as a visual stimulus of a calibration point. In an embodiment, the center of the pupil of the camera image of the user's eye represents the coordinates of the calibration point on the user display. In another embodiment, the center of the corneal reflection of the camera image of the user's eye represents the coordinates of the calibration point on the user display.

Abstract: The present invention relates to a pharmaceutical composition, comprising a PPAR agonist, or pharmaceutically acceptable salts thereof, alone or in combination with at least one active ingredient selected from the group consisting of (i) HDL increasing compounds; (ii) anti-diabetics; (iii) an anti-hypertensive agent; (iv) cholesterol absorption modulator; (v) apo-A1 analogs and mimetics; (vi) renin inhibitors; (vii) thrombin inhibitors; (viii) aldosterone inhibitors; (ix) GLP-1 agonists; (x) glucagon receptor antagonists; (xi) cannabinoid receptor 1 antagonists; (xii) anti-obesity agents; and (xiii) inhibitors of platelet aggregation or, in each case, a pharmaceutically acceptable salt thereof; and optionally a pharmaceutically acceptable carrier.

Abstract: A radio communication system (100) has distributed operational control. Multiple autonomously operable computer workstations (120) are linked to a radio communication database (175) via a computer network (130). A local database (211), corresponding to a view of the radio communication database (175), is stored on each computer system (120). A radio system console operator interface (206) is configured according to information in the local database (211), and is operated to perform operational control of a portion of the radio communication system (100). Data consistency of the information stored in the local database (211) is automatically maintained.

Abstract: A computer system (110) has a multi-processing software application operating (200) thereon. There are multiple client processes (221-228) concurrently operating as components of the multi-processing software application (200). Termination of the multi-processing software application (200) results from individual decisions made at each client process (221-228). If a particular client process determines that another client process is inoperable (530), the particular client process continues operation when the inoperable process is designated non-mandatory (550, 510), and terminates operation when the inoperable process is designated mandatory (550, 580, 598). Furthermore, when the inoperable process is designated single-instance mandatory and belongs to a particular process class, the particular client process continues operation unless it is the only member of the process class operating (580, 590, 595, 598).

Abstract: A multi-processing software system (200) has multiple operating processes (221, 222, 223, 224, 225, 226, 227, 228) that communicate with each other using messages. Each process has a corresponding process class (410, 411, 412, 413). Each message is assigned a message type (450, 451, 452, 453), and messages types are mapped (400) to least one process class. A particular message is routed to processes having a process class corresponding to the one or more process classes mapped to the message type of the particular message.

Abstract: Sample preparation apparatus for forming a thin layer of diluted blood specimen on a substrate by centrifugal force includes a sample probe having coaxial blood and diluent conduits coupled to respective reversibly-drivable peristaltic pumps having forward operation intakes connected to a diluent supply. A one-way clutch limits the diluent pump to forward operation and the pumps are geared to produce a blood-to-diluent displacement ratio of 2:1. A substrate holder is mounted on a carriage for selective insertion into and removal from a sealed centrifuge chamber in which it is spun at a high angular rate by a drive motor. Means are provided to form a curtain of flowing liquid within the chamber surrounding the spinning substrate to collect spun-off blood particles and aerosol. The liquid forming the curtain is drained by an exhaust pump which operates after spinning has ceased so as to create a partial vacuum for draining off residual aerosol prior to unsealing the centrifuge chamber.

Abstract: Sample preparation apparatus for forming a thin layer of diluted blood specimen on a substrate by centrifugal force includes a sample probe having coaxial blood and diluent conduits coupled to respective reversibly drivable peristaltic pumps having forward operation intakes connected to a diluent supply. A one-way clutch limits the diluent pump to forward operation and the pumps are geared to produce a blood-to-diluent displacement ratio of 2:1. A substrate holder is mounted on a carriage for selective insertion into and removal from a sealed centrifuge chamber in which it is spun at a high angular rate by a drive motor. Means are provided to form a curtain of flowing liquid within the chamber surrounding the spinning substrate to collect spun-off blood particles and aerosol. The liquid forming the curtain is drained by an exhaust pump which operates after spinning has ceased so as to create a partial vacuum for draining off residual aerosol prior to unsealing the centrifuge chamber.

Abstract: Sample preparation apparatus for forming a thin layer of diluted blood specimen on a substrate by centrifugal force includes a sample probe having coaxial blood and diluent conduits coupled to respective reversibly-drivable peristaltic pumps having forward operation intakes connected to a diluent supply. A one-way clutch limits the diluent pump to forward operation and the pumps are geared to produce a blood-to-diluent displacement ratio of 2:1. A substrate holder is mounted on a carriage for selective insertion into and removal from a sealed centrifuge chamber in which it is spun at a high angular rate by a drive motor. Means are provided to form a curtain of flowing liquid within the chamber surrounding the spinning substrate to collect spun-off blood particles and aerosol. The liquid forming the curtain is drained by an exhaust pump which operates after spinning has ceased so as to create a partial vacuum for draining off residual aerosol prior to unsealing the centrifuge chamber.

Abstract: The invention relates to a system for propulsion utilizing a vapor heat transfer generator to create high pressure steam directly from water vapor which is transferred to rotary cylinder motors of positive displacement design, which are run on ball and roller bearings to eliminate friction facilitating high speed operation.